How aneuploidy may cause cancer and genetic instability

Anticancer Research

Volumn 19, Issue 6 A, 1999, Pages 4887-4906

  Duesberg, Peter ^a   Rasnick, David ^a   Li, Ruhong ^a   Winters, Leslie ^a   Rausch, Charlotte ^b   Hehlmann, Ruediger ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aneuploidy; Cancer; Carcinogenesis; Genetic instability

Indexed keywords

CARCINOGEN; CELL PROTEIN;

ANEUPLOIDY; CANCER; CANCER GROWTH; CANCER INVASION; CELL CLONE; CELL METABOLISM; CELL STRUCTURE; CHROMOSOME SEGREGATION; DOWN SYNDROME; GENE MUTATION; GENETIC STABILITY; GENOTOXICITY; HUMAN; KARYOTYPE; METABOLIC REGULATION; MITOSIS SPINDLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANEUPLOIDY; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; KARYOTYPING; MUTATION; NEOPLASMS; PHENOTYPE;

EID: 0033396407     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Cairns J: Cancer: Science and Society. San Francisco, W. H. Freeman and Company, 1978.
2. Pitot HC: Fundamentals of Oncology. New York, Marcel Dekker, Inc., 1986.
3. Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J: Molecular Cell Biology. New York and Oxford UK, Scientific American Books, Inc. by W. H. Freeman & Co., 1995.
4. Stedman's Medical Dictionary: Baltimore, Williams & Wilkins, 1982.
5. Nowell PC: The clonal evolution of tumor cell populations. Science 194: 23-28, 1976.
6. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature (London) 386: 623-627, 1997.
7. Heppner G, Miller FR: The cellular basis of tumor progression. International Review of Cytology 177: 1-56, 1998.
8. Watson JD, Hopkins NH, Jeffrey WR, Steitz JA, Weiner AM: Molecular Biology of the Gene. New York, Benjamin, 1987.
9. Hansemann D: Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Virchows Arch Pathol Anat 119: 299-326, 1890.
10. Boveri T: Zur Frage der Entstehung maligner Tumoren. Jena, Germany, Gustav Fischer Verlag, 1914.
11. Bauer K-H: Mutationstheorie der Geschwulstentstehung. Berlin, 1928.
12. Graffi A, Bielka H: Probleme der experimentellen Krebsforschung. Leipzig, Academische Verlags Gesellschaft Geest & Portig K.-G., 1959.
13. Bauer K.H.: Das Krebsproblem. Berlin, Göttingen, Heidelberg, Springer Verlag, 1963.
14. Sandberg AA: The chromosomes in human cancer and leukemia. New York, Elsevier Science Publishing, 1990.
15. Pennisi E: Trigger for centrosome replication found. Science 238: 770-771, 1999.
16. Brinkley BR, Goepfert TM: Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motility and the Cytoskeleton 41: 281-288, 1998.
17. Duesberg PH, Vogt PK: Differences between the ribonucleic acids of transforming and non-transforming avian tumor viruses. Proc Natl Acad Sci 67: 1673-1680, 1970.
18. Duesberg PH: Transforming genes of retroviruses. Cold Spring Harbor Symp Quant Biol 44: 13-29, 1980.
19. Bishop JM: Cellular oncogenes and retroviruses. Annu Rev Biochem 52: 301-354, 1983.
20. Lewin B: Genes V. Oxford, Oxford University Press, 1994.
21. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular Biology of the Cell. New York, Garland Publishing, Inc., 1994.
22. Duesberg PH: Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res 47: 1199-1220, 1987.
23. Duesberg PH, Schwartz JR: Latent viruses and mutated oncogenes: no evidence for pathogenicity. Prog Nucleic Acid Res Mol Biol 43: 135-204, 1992.
24. Duesberg PH: Inventing the AIDS Virus. Washington, Regnery Publishing Inc., 1996.
25. Fujimura J: Crafting science: a sociohistory of the quest for the genetics of cancer. Cambridge, MA. Harvard University Press, 1996.
26. Bailar JC, Gorink HL: Cancer undefeated. New Engl J Med 336: 1569-1574, 1997.
27. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46: 5-27, 1996.
28. Beardsley T: A war not won. Scientific American 1994; January, pp130-138.
29. Winge O: Zytologische Untersuchungen über die Natur maligner Tumoren. II. Teerkarzinome bei Mäusen. Zeitschrift fur Zellforschung und Mikroskopische Anatomie 10: 683-735, 1930.
30. Hauschka TS: The chromosomes in ontogeny and oncogeny. Cancer Res 21: 957-981, 1961.
31. Mitelman F: Catalogue of chromosome aberrations in cancer. New York, Wiley-Liss, 1994.
32. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genetics 15, Supplement, April 1997: 417-474, 1997.
33. Heim S, Mitelman F: Cancer Cytogenetics. New York, Wiley-Liss, 1995.
34. Li R, Yerganian G, Duesberg P, Kraemer A, Willer A, Rausch C, Hehlmann R: Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci (USA) 94: 14506-14511, 1997.
35. Benedict WF: Early changes in chromosomal number and structure after treatment of fetal hamster cultures with transforming doses of polycyclic hydrocarbons. J Natl Cancer Inst 49: 585-590, 1972.
36. Trott DA, Cuthbert AP, Overell RW, Russo I, Newbold RF: Mechanisms involved in the immortalization of mammalian cell by ionizing radiation and chemical carcinogens. Carcinogenesis 16: 153-204, 1995.
37. Merriam-Webster: Webster's Third International Dictionary; Springfield, MA, G. & C. Merriam Co., 1965.
38. Bialy H: Aneuploidy and cancer: vintage wine in a new bottle? Nature Biotechnology 16: 137-138, 1998.
39. Orr-Weaver TL, Weinberg RA: A checkpoint on the road to cancer. Nature (London) 392: 223-224, 1998.
40. Heim S, Mitelman F: Cancer Cytogenetics. New York, Alan R. Liss, Inc., 1987.
41. Andres AH: Zellstudien an Menschenkrebs. Der Chromosomale Bestand im Primärtumor und in der Metastase. Zeitschrift für Zellforschung und Mikroskopische Anatomie 16: 88-122, 1932.
42. Johansson B, Mertens F, Mitelman F: Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Genes Chromosomes & Cancer 16: 155-163, 1996.
43. Heim S, Mandahl N, Mitelman F: Genetic convergence and divergence in tumor progression. Cancer Res 48: 5911-5916, 1988.
44. Rubin H: Cancer as a dynamic developmental disorder. Cancer Res 45: 2935-2942, 1985.
45. Hlozanek I, Donner L, Svoboda J: Malignant transformation in vitro of Chinese hamster embryonic fibroblasts with the Schmidt-Ruppin strain of Rous sarcoma virus and karyological analysis of this process. J Cell Physiol 68: 221-235, 1966.
46. Rubin H, Temin HM: Infection with the Rous sarcoma virus in vitro. Fed Proc 17: 994-1008, 1958.
47. Mitelman F: The Rous sarcoma virus story: cytogenetics of tumors induced by RSV; in German J (ed.): Chromosomes and cancer. John Wiley & Sons, Inc., 1974, pp 675-693.
48. Galloway SM, Buckton KE: Aneuploidy and ageing: chromosome studies on a random sample of the population using G-banding. Cytogenet Cell Genet 20: 78-96, 1978.
49. Harnden DG, Benn PA, Oxford JM, Taylor AMR, Webb TP: Cytogenetically marked clones in human fibroblasts cultured from normal subjects. Somatic Cell Genetics 2: 55-62, 1976.
50. Cram LS, Bartholdi MF, Ray FA, Travis GL, Kraemer PM: Spontaneous neoplastic evolution of Chinese hamster cells in culture: Multistep progression of karyotype. Cancer Res 43: 4828-4837, 1983.
51. Lijinsky W: A view of the Relation Between Carcinogenesis and Mutagenesis. Env Mol Mutagenesis 14: 78-84, 1989.
52. Ames B, Durston WE, Yamaski E, Lee FD: Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70: 2281-5, 1973.
53. Burdette WJ: The significance of mutation in relation to origin of tumors. Cancer Res 75: 201-226, 1955.
54. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B: Mutations of mitotic checkpoint genes in human cancers. Nature (London) 392: 300-303, 1998.
55. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF: Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747, 1996.
56. Haber DA, Fearon ER: The promise of cancer genetics. The Lancet 351: SII1-SII8, 1998.
57. Duesberg P: Oncogenes and Cancer (letter). Science 267: 1407-1408, 1995.
58. Hua VY, Wang W, K., Duesberg PH: Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc Natl Acad Sci USA 94: 9614-9619, 1997.
59. Cooper GM: Oncogenes. Boston, Jones and Bartlett Publishers, 1990.
60. Watson JD: Molecular Biology of the Gene. New York, Benjamin, 1970.
61. Kacser H, Burns JA: The molecular basis of dominance. Genetics 97: 639-666, 1981.
62. Marx J: Oncogenes Reach a Milestone. Science 266: 1942-1944, 1994.
63. Strauss BS: The origin of point mutations in human tumor cells. Cancer Res 52: 249-253, 1992.
64. Hollstein M, Rice K, Greenblatt MS, Soussi R, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, C HC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
65. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
66. Roy-Burman P, Zheng J, Miller GJ: Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis? Molecular Medicine Today November: 476-482, 1997.
67. Kinzler K, Vogelstein B: Lessons from hereditary cancer. Cell 87: 159-170, 1996.
68. Oshimura M, Barrett JC: Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environmental Mutagenesis 8: 129-159, 1986.
69. Stanbridge EJ: Human Tumor Suppressor Genes. Annu Rev Genet 24: 615-657, 1990.
70. Thraves P, Reynolds S, Salehi Z, Kim WK, Yang JH, Rhim JS, Dritschilo A: Detection of transforming genes from radiation transformed human epidermal keratinocytes by a tumorigenicity assay: in Rhim JS, Dritschilo A (ed.): Neoplastic transformation in human cell culture. Totowa, NJ, The Humana Press Inc., 1991, pp93-101.
71. Augenlicht LH, Wahrman MZ, Halsey H, Anderson L, Taylor J, Lipkin M: Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res 47: 6017-6021, 1987.
72. Cha RS, Thilly WG, Zarbl H: N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic H-ras1 gene mutations. Proc Natl Acad Sci USA 91: 3749-3753, 1994.
73. Balmain A, Ramsden M, Bowden GT, Smith J: Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature (London) 307: 658-660, 1984.
74. Chakraborty AK, Cichutek K, Duesberg PH: Transforming function of proto-ras genes depends on heterologous promoters and is enhanced by specific point mutations. Proc Natl Acad Sci USA 88: 2217-2221, 1991.
75. Li R, Zhou R-P, Duesberg P: Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells. Proc Natl Acad Sci 93: 7522-7527, 1996.
76. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL: Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4: 715-721, 1989.
77. Lindgren V, Sippola-Thiele M, Skowronski J, Wetzel E, Howley PM, Hanahan D: Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic mice. PNAS USA 86: 5025-5029, 1989.
78. Donehower LA, Harvey M, Siagle BL, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (London) 356: 215-221, 1992.
79. German J: Bloom's syndrome. II. The prototype of genetic disorders predisposing to chromosome instability and cancer; in German J (ed.): Chromosomes and Cancer. New York, John Wiley & Sons, 1974, pp 601-617.
80. Cairns J: Matters of Life and Death; perspectives on public health, molecular biology, cancer, and the prospects for the human race. Princeton, New Jersey, Princeton University Press, 1997.
81. Cairns J: The origin of human cancers. Nature (London) 289: 353-357, 1981.
82. Benedict WF, Banerjee A, Mark C, Murphree AL: Non-random retinoblastoma gene is a recessive cancer gene. Cancer Genet Cytogenet 10: 311-333, 1983.
83. Hassold TJ: Chromosome abnormalities in human reproductive wastage. Trends in Genetics 2: 105-110, 1986.
84. Rubin H: Understanding Cancer. Science 219: 1170-1171, 1982.
85. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075-3079, 1991.
86. Duesberg P, Rausch C, Rasnick D, Hehlmann R: Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci USA 95: 13692-13697, 1998.
87. Loeb LA: Transient Expression of a Mutator Phenotype in Cancer Cells. Science 277: 1449-1450, 1997.
88. Cairns J, Logan J: Step by step into carcinogenesis. Nature (London) 304: 582-583, 1983.
89. Newbold RF: Multistep malignant transformation of mammalian cells by carcinogens: induction of immortality as a key event; in Barrett JC, Tennant RW (ed.): Mechanism of carcinogenesis and assays for carcinogens. New York, Raven Press, 1985, pp 17-28.
90. Kinzler KW, Vogelstein B: Gatekeepers and caretakers. Nature (London) 386: 761-762, 1997.
91. Wu Y, Duesberg P: Avian erythroblastosis virus E26: Only one (myb) of two cell-derived coding regions is necessary for oncogenicity. Proc Natl Acad Sci USA 91: 4039-4043, 1994.
92. Weinberg RA: Racing to the beginning of the road: the search for the origin of cancer. New York, Freeman & Co., 1998.
93. Anonymous: Vignettes: Weighing words. Science 275: 1439, 1997.
94. Duesberg PH: Activated proto-onc genes: sufficient or necessary for cancer? Science 228: 669-677, 1985.
95. Duesberg PH: Transforming genes in normal cells? Nature (London) 304: 219-226, 1983.
96. Tjio JH, Levan A: The chromosome number of man. Hereditas 44: 451-465, 1956.
97. Caspersson T, Zech L, Johansson C: Differential handing of alkylating fluorochromes in human chromosomes. Exp Cell Res 60: 315-319, 1970.
98. Lejeune J, Turpin R, Gautier M: Le Mongolisme, premier exemple d'abberation autosomique humaine. Ann Genet 2: 41-49, 1959.
99. Shapiro BL: Down syndrome - a disruption of homeostasis. Am J Medical Genetics 14: 241-269, 1983.
100. Epstein C: The consequences of chromosome imbalance: principles, mechanisms, and models. Cambridge, London, New York, Cambridge University Press, 1986.
101. Sandler L, Hecht F: Genetic effects of aneuploidy. Amer J Hum Genet 25: 332-339, 1973.
102. Lindsley DL, Sandler L, Baker BS, Carpenter ATC, Denell RE, Hall JC, Jacobs PA, Gabor Miklos GL, Davis BK, Gethmann RC, Hardy RW, Hessler A, Miller SM, Nozawa H, Parry DM, Gould-Somero M: Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics 71: 157-184, 1972.
103. Burke D, Gasdaska P, Hartwell L: Dominant effects of tubulin overexpression in Saccharomyces cerevisiae. Mol & Cell Biol 9: 1049-1059, 1989.
104. Mayer VW, Aguilera A: High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. Mutat Res 231: 177-186, 1990.
105. Fell D: Understanding the control of metabolism. London and Miami, Portland Press, 1997.
106. Rasnick D, Duesberg P: How aneuploidy affects metabolic control and causes cancer. Biochem J 340: 621-630, 1999.
107. Cornish-Bowden A: Kinetics of multi-enzyme systems; in Rehm H-J, Reed G (ed.): Biotechnology. Weinheim, New York, Basel, VCH, PO Box 101161, Weinheim, Germany, 1995, pp121-136.
108. Heinrich R, Rapoport TA: Linear theory of enzymatic chains; its application for the analysis of the crossover theorem and of the glycolysis of human erythrocytes. Acta Biologica et Medica Germanica 31: 479-494, 1973.
109. Heinrich R, Rapoport TA: A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. European Journal of Biochemistry 42: 89-95, 1974.
110. Kurnit DM: Down syndrome; gene dosage at the transcriptional level in skin fibroblasts. PNAS USA 76: 2372-2375, 1979.
111. Lewis R: Genetic imprecision. BioScience 41: 288-293, 1991.
112. Caspersson TO: Disturbed systems for protein formation in the metazoan cell: in: Cell growth and cell function: A cytochemical study. New York, W. W. Norton & Co., 1950, pp 141-151.
113. Caspersson T, Foley GE, Killander D, Lomakka G: Cytochemical differences between mammalian cell lines of normal and neoplastic origins: correlation with heterotransplantability in Syrian hamsters. Experimental Cell Res 32: 553-565, 1963.
114. Wolman S: Karyotype progression in human tumors. Cancer Metastasis Rev 2: 257-293, 1983.
115. Foley GE, Handler AH, Lynch PM, Stulberg CS, Eagle H: Loss of neoplastic properties in vitro: observations on KB sublines. Cancer Res 25: 1254-1261, 1965.
116. Sennerstam R, Kato H, Auer GU: Dissociation of cellular protein and DNA content in mild and moderate dysplasia as a reflection of the degree of aneuploidy in cancer. Anal Quant Cytol & Histol 11: 255-260, 1989.
117. Holliday R: Chromosome error propagation and cancer. Trends Genet 5: 42-45, 1989.
118. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 276: 1268-1272, 1997.
119. Jensen JC, Thilly WG: Spontaneous and induced chromosomal aberrations and gene mutations in human lymphoblasts: mitomycin C, methylnitrosourea, and ethylnitrosourea. Mutat Res 160: 95-112, 1986.
120. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature (London) 327: 293-297, 1987.
121. Matsuoka A, Ozaki M, Takeshita K, Sakamoto H, Glatt H, Hayashi M, Sofuni T: Aneuploidy induction by benzo[a]pyrene and polyploidy induction by 7,12-dimethylbenz[a]anthracene in Chinese hamster cell lines V79-MZ and V79. Mutagenesis 12: 365-372, 1997.
122. Futcher B, Carbon J: Toxic effects of excess cloned centromeres. Mol & Cell Biol 6: 2213-2222, 1986.
123. American Type Culture Collection: Catalogue of cell lines & hybridomas. Rockville, MD, American Type Culture Collection, 1992.
124. Holliday R: Neoplastic transformation: the contrasting stability of human and mouse cells; in Lindhal T, Tooze J (ed.): Genetic instability in cancer. Plainview, NY, Cold Spring Harbor Lab Press, 1996, pp 103-115.
125. Parry JM, Parry EM, Bourner R, Doherty A, Ellard S, O'Donovan J, Hoebee B, de Stoppelaar JM, Mohn GR, Oenfelt A, et al: The detection and evaluation of aneugenic chemicals. Mutat Res 353: 11-46, 1996.
126. Yamasaki H, Ashby J, Bignami M, Jongen W, Linnainmaa K, Newbold RF, Nguyen-Ba G, Parodi S, Rivedal E, Schiffmann D, Simons JWIM, Vassuer P: Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat Res 353: 47-63, 1996.
127. Cimino M, Tice RR, Liang JC: Aneuploidy in mammalian somatic cells in vivo. Mutat Res 167: 107-122, 1986.
128. Aardema MJ, Albertini S, Arni P, Henderson LM, Kirsch-Volders M, Mackay JM, Sarrif DA, Stringer DA, Taalman RDF: Aneuploidy: a report of an ECETOC task force. Mutat Res 410: 3-79, 1998.
129. Oenfelt A: Mechanistic aspects on chemical induction of spindle disturbances and abnormal chromosome numbers. Mutat Res 168: 249-300, 1986.
130. Craddock VM: Reaction of the carcinogen dimethylnitrosamine with proteins and with tricol compounds in the intact animal. Biochem J 94: 323-330, 1965.
131. Brookes P, Lawley PD: Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic potential of hydrocarbons and their binding to deoxyribonucleic acid. Nature (London) 202; 781-784, 1964.
132. Kumari HL, Milo GE, Witiak DT: Cytotoxicity, anchorage-independent growth, and DNA adduct formation in human fibroblasts by 1,2,3,4-tetrahydro-7,12-dimethylbenz(a)-anthracene (TH-DMBA), its aryl fluoro regioisomers, and an exo methylene tautomer. Teratogenesis, Carcinogenesis, and Mutagenesis 10: 247-262, 1990.
133. Chakravarti D, Felling JC, Cavalieri EL, Rogan EG: Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc Natl Acad Sci USA 92: 10422-10426, 1995.
134. Tomlinson I, Bodmer W: Selection, the mutation rate and cancer: insuring that the tale does not wag the dog. Nature Medicine 5: 11-12, 1999.
135. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature (London) 396: 643-649, 1998.
136. Weinberg RA: The cat and mouse games that genes, viruses, and cells play. Cell 38: 573-575, 1997.
137. Gross L: Oncogenic Viruses. Oxford, UK, Pergamon, 1970.
138. Weiss R, Teich N, Varmus H, Coffin J: Molecular Biology of RNA Tumor Viruses. Plainview, NY, Cold Spring Harbor Lab. Press, 1985.
139. Tooze: The Molecular Biology of Tumour Viruses. New York, Cold Spring Harbor, 1973.
140. Duesberg PH: Cancer genes: rare recombinants instead of activated oncogenes. Proc Natl Acad Sci USA 84: 2117-2124, 1987.
141. Groudine M, Weintraub H: Activation of cellular genes by avian RNA tumor viruses. Proc Natl Acad Sci USA 77: 531-534, 1980.
142. Koeffler HP, Golde DW: Chronic Myelogenous Leukemia - New Concepts - Part I. N Engl J Med 304: 1201-1209, 1981.
143. Koeffler HP, Golde DW: N Engl J Med 304: 1269-1274, 1981.
144. Sadamori N, Gomez GA, Sandberg AA: Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph-positive chronic myeloid leukemia. Blood 61: 935-939, 1983.
145. Heim S: Clonal chromosome abnormalities in neoplastic cells: evidence of genetic instability?; in Tooze J (ed.): Genetic instability in cancer. Plainview, NY, Cold Spring Harbor Laboratory Press, 1996, pp 247-260.